Sponsors (6)
The bill provides a modest, targeted DoD investment to accelerate validation and domestic manufacturing of improved TBI diagnostics—improving diagnosis and readiness for service members—while leaving broader civilian treatment access, longer-term support, and some competitive openness uncertain.
Military personnel (service members) are likely to get faster and more accurate TBI diagnosis in combat and operational settings, improving immediate care, survival chances, return-to-duty decisions, and long-term brain-health monitoring.
U.S. companies, small businesses, and nonprofits receive targeted grants and pilot support that accelerate RDT&E and manufacturing scale-up for promising TBI diagnostics, helping promising technologies move toward production and commercialization.
Including DoD clinicians, trauma centers, and service members in studies increases the practical relevance of validations so diagnostics are more likely to work in real-world military care pathways.
Pilot funds are limited to validation, RDT&E, and manufacturing support and therefore are unlikely to expand or directly fund clinical treatment or broader access to care for civilians or all service members.
The pilot program is time-limited (terminates Sept. 30, 2029), so promising technologies may lose momentum or require additional follow-on funding to reach widespread deployment.
Grant preferences for entities within the national technology and industrial base or with prior history may disadvantage newer small innovators or foreign firms, potentially reducing competition and excluding some cost-effective solutions.
Based on analysis of 2 sections of legislative text.
Directs DoD to create a pilot to evaluate and support development, testing, and production of TBI diagnostic technologies for service members and authorizes grants to eligible entities.
Introduced December 17, 2025 by Lori Trahan · Last progress December 17, 2025
Creates a Department of Defense pilot program to evaluate, accelerate, and help transition diagnostic technologies for traumatic brain injury (TBI) that can be used with service members in operational and combat settings. The pilot must be set up within 180 days, assess feasibility of supporting manufacturers and developers, evaluate diagnostic performance and integration with other clinical tools and sensors, and enable research, development, testing, evaluation, and transition to production through grants to eligible entities.